Analysguiden/Carlsquare updates its view on Ascelia Pharma and raises target share price
Today Analysguiden/Carlsquare published an updated equity research report on Ascelia Pharma. As part of their updated view, they raise their target share price to 41.90 kr from 34.80 kr.The full report can be found here: https://www.aktiespararna.se/analysguiden/nyheter/analys-ascelia-fas-iii-med-mangoral For more information, please contact:Magnus Corfitzen, CEOEmail: moc@ascelia.com Tel: +46 735 179 110 Mikael Widell, IR & Communications ManagerEmail: mw@ascelia.com Tel: +46 703 11 99 60 About Ascelia PharmaAscelia Pharma is an